Suicide thoughts in hereditary angioedema
Part of Genetic & congenital, Heart & circulation, Immune system & allergy, Skin clinical trials.
This study looks at whether people with hereditary angioedema (a rare condition causing sudden swelling) experience thoughts of suicide. The goal is to understand the emotional impact of living with this condition and find ways to support patients better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with hereditary angioedema.
- You are 18 years old or older.
- You do not have an intellectual disability.
- You are willing to participate in the study.
- Your angioedema is not caused by an acquired condition (not hereditary).
- You do not have other skin diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if a blood test measuring C1-inhibitor function can help diagnose hereditary angioedema (HAE), a rare condition that causes painful swelling episodes. If you or a close family member have had swelling without rash or itching that lasts 1-5 days and doesn't get better with allergy meds, this trial may be for you.
This study is looking at how hereditary angioedema (a rare cause of severe swelling) is diagnosed and managed in Egypt. It is an observational study, meaning you won't receive any study medicine—just regular medical care while researchers collect information.
This study is an extension trial of an oral medicine (PHA-022121) for treating acute attacks in people with hereditary angioedema (HAE), especially HAE type III (HAE-nC1INH). It checks whether continuing this oral treatment can safely help manage attacks after you’ve taken it before.
This study is for people who already finished a previous trial of the drug ADX-324 for hereditary angioedema. It tests the long-term safety and effectiveness of continuing the medication.
This study tests a daily oral tablet called deucrictibant to see if it can prevent swelling attacks in people with hereditary angioedema (HAE). If you join, you will take the study drug for a longer period and track your symptoms in a diary.
This study looks at the genes that cause hereditary angioedema (HAE), a condition with sudden swelling in the hands, feet, face, or airways. By joining, you help doctors understand the disease better, which could lead to better care for you and others.
Hear when a new Hereditary Angioedema (HAE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.